Jagsonpal Pharmaceuticals Limited - Technical chart

consolidated in Rs/Cr.

Industry

Industry name

Pharmaceuticals
Variance

Full Year Net Profit Variance

41
Equity

Latest Equity

13.21
Face Value

Latest Face Value

2
Reserves

Total Reserve

230.59
Dividend

Full Year Dividend %

200
Sales Turnover

Full Year Net Sales

287.23
Net Profit

Full Year Net Profit

44.64
Full Year CPS

Full Year Cash Per Share

8.2
Earning Per Share

Full Year Earning Per Share

6.8
Quarter CPS

Latest quarter Cash Per Share

0
Latest Quarter Date

Latest Quarter Yrc

Sep 1, 2026
Latest Quarter Sales

Latest Quarter Net Sales

81.38
Previous EPS

Previous earnings per share

0
Book Value

Book value

36.9
Networth

Full Year Return on Networth

16.69
Price/Book Value

Price to Book value

5.934959
Yearly PE ratio

Full Year Price to Earning per share

32.4
Yearly PC ratio

Full Year Price to Cash Per Share

26.7
Bse value

BSE Value in lakhs

6.16
Nse value

NSE Value in lakhs

108.37
High

52 week high

265
Low

52 week low

155
Price

NSE Current market price

220
CPM

Current market price

219
Market cap

BSE / NSE Market Cap

1449.34
Net profit

Latest Quarter Net Profit

12.77
Net profit variance

Latest Quarter Net Profit variance

2
Result year

Trailing latest month

Sep 1, 2026
TTM Sales

Trailing Twelve 12 month Net Sales

226.85
TTM OP

Trailing Twelve 12 month Operating Profit

31.62
TTM OPM

Trailing Twelve 12 month Operating Profit Margin

13.94
TTM GP

Trailing Twelve 12 month Gross Profit

69.32
TTM GPM

Trailing Twelve 12 month Gross Profit Margin

23.05
TTM NP

Trailing Twelve 12 month Net Profit

26.76
TTM NPV

Trailing Twelve 12 month Net Profit Variane

7.91
TTM EPS

Trailing Twelve 12 month EPS

7.15
TTM PE

Trailing Twelve 12 month PE

30.69
TTM CPS

Trailing Twelve 12 month CPS

0
Month CPS

Month Cash Per Share

0
TTM Depreciation

Trailing Twelve 12 month Depreciation

4.23
Equity

Latest Equity

13.21
LTP

Latest Price (BSE/NSE)

219
Gross block

Latest Gross Block

102
Loans

Total loans

8.17
Advances

Latest Advances for Banks

0
Net profit asset

Latest Assets

0
Year OPM

Full Year Operating Profit Margin

20.2
Year GPM

Full Year Gross Profit Margin

24
Quarter OPM

Latest quater Operation Profit Margin

20.6

Quarterly Results (consolidated, figures in Rs Cr.)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
+ Sales 74 59 76 74 73 64 82 96
YOY Sales Growth % 57% 35% 23% -0% -1% 10% 9% 29%
Gross Sales 74 59 76 74 73 64 82 96
+ Expenses 58 50 61 58 59 53 65 80
Material Cost % 7% 5% 8% 6% 6% 3% 9% 4%
Raw Material Cost 5 3 5 4 4 3 5 5
Change in Inventory 0 -1 1 0 0 -1 2 0
Manufacturing Cost % 18% 20% 20% 17% 20% 21% 17% 16%
Employee Cost % 24% 28% 26% 24% 24% 24% 28% 24%
Other Cost % 29% 32% 27% 31% 30% 34% 26% 38%
Raw Materials % 7% 6% 7% 5% 5% 5% 6% 5%
Purchase of Finished Goods % 29% 30% 30% 32% 31% 31% 32% 37%
Stock Adjustments % 0% 1% -1% -1% -0% 1% -3% 0%
Other Manufacturing Expenses % 18% 20% 20% 17% 20% 21% 17% 16%
Operating Profit 16 9 14 16 14 11 17 17
OPM % 21% 15% 19% 22% 19% 17% 21% 17%
+ Other Income 26 3 3 3 3 3 3 2
Miscellaneous Income 26 3 3 3 3 3 3 2
Exceptional Income 23 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 2
Profit before tax 39 9 14 17 15 12 18 16
+ Tax % 17% 24% 25% 25% 25% 25% 25% 25%
Current Tax 8 1 3 4 4 2 4 4
Deferred Tax -1 1 0 0 0 1 0 0
+ Net Profit 32 7 11 13 11 9 13 12
Extraordinary Income / Expense 23 0 0 0 -2 0 0 0
Exceptional Item 23 0 0 0 -2 0 0 0
Net Profit After Minority Interest 13 12
EPS in Rs 2.00 1.86

Profit & Loss (consolidated, figures in Rs Cr.)

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
+ Sales 145 127 167 159 188 218 237 209 269 287
Sales Growth % -13% 32% -5% 19% 16% 9% -12% 29% 7%
Gross Sales 143 126 167 159 188 219 237 209 269 287
Excise Duty 1 0 0 0 0 0 0 0 0 0
Other Operating Income 0 0 0 0 0 0 0 0 0 0
+ Expenses 139 138 158 150 169 193 206 186 221 231
Material Cost % 41% 48% 44% 35% 43% 41% 39% 38% 36% 36%
Raw Material Cost 67 65 53 55 76 83 88 76 99 105
Change in Inventory -8 -4 19 1 5 6 4 4 -2 -1
Manufacturing Cost % 2% 2% 1% 1% 1% 1% 0% 0% 1% 1%
Employee Cost % 28% 33% 28% 32% 29% 27% 28% 30% 26% 25%
Other Cost % 25% 26% 22% 27% 18% 20% 20% 20% 20% 19%
Raw Materials % 46% 51% 32% 35% 40% 38% 37% 36% 37% 37%
Purchase of Finished Goods % 9% 23% 9% 11% 20% 23% 24% 26% 30% 31%
Stock Adjustments % 6% 3% -12% -1% -3% -3% -2% -2% 1% 0%
Power & Fuel % 1% 1% 1% 0% 0% 0% 0% 0% 0% 0%
Other Manufacturing Expenses % 1% 1% 0% 0% 0% 0% 0% 0% 0% 1%
Selling & Administration % 21% 22% 19% 24% 17% 20% 18% 20% 18% 18%
Miscellaneous Expenses % 3% 4% 2% 3% 1% 1% 3% 1% 2% 1%
Operating Profit 6 -11 9 9 19 25 31 23 47 56
OPM % 4% -9% 6% 5% 10% 12% 13% 11% 18% 19%
+ Other Income 13 0 1 3 4 3 6 9 32 12
Miscellaneous Income 13 0 1 3 4 3 6 9 31 12
Exceptional Income 13 0 0 0 0 0 0 0 23 0
Interest 3 1 1 1 1 0 0 1 1 1
Depreciation 2 0 1 1 1 2 1 2 8 9
Profit before tax 14 -12 9 9 22 27 35 30 70 58
+ Tax % 18% 1% 20% 16% 22% 29% 23% 25% 21% 25%
Current Tax 3 0 2 2 6 7 8 8 14 13
Deferred Tax 0 0 0 0 -1 0 0 0 1 1
+ Net Profit 12 -12 7 8 17 19 27 22 55 43
Profit Growth % -197% -162% 9% 117% 12% 40% -16% 146% -22%
Extraordinary Income / Expense 13 0 0 0 0 0 -3 0 20 -2
Exceptional Item 13 0 0 0 0 0 -3 0 20 -2
EPS in Rs

Balance Sheet (consolidated, figures in Rs Cr.)

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 13 13 13 13 13 13 13 13 13 13
Reserves 97 85 91 98 109 120 146 174 226 261
+ Borrowings 8 8 4 5 7 0 6 9 9 8
Secured Borrowings 0 0 -2 -2 0 0 0 0 0 0
Unsecured Borrowings 8 8 6 6 7 0 6 9 9 8
+ Other Liabilities 25 23 28 31 35 31 30 21 29 34
Current Liabilities 25 23 28 31 36 31 31 22 30 34
Provisions 5 5 7 8 5 1 0 1 1 2
Equity Application Money 0 0 0 0 0 0 0 0 0 2
Other liability items 0 0 0 0 0 1 1 1 2 1
Total Liabilities 143 130 136 147 164 164 195 217 278 317
+ Fixed Assets 22 21 22 22 26 23 24 9 94 85
Gross Block 53 54 55 56 60 58 33 12 103 102
Accumulated Depreciation 31 32 33 34 34 36 9 2 9 17
CWIP 0 3 4 4 0 0 0 0 0 0
Investments 0 0 0 11 15 51 1 0 0 0
+ Other Assets 121 105 110 109 123 91 170 208 184 231
Inventories 48 51 33 29 30 30 21 15 15 15
Trade receivables 39 25 21 21 13 16 21 11 13 17
Cash Equivalents 20 15 39 38 60 25 115 148 129 106
Loans n Advances 3 4 6 6 15 18 10 25 6 8
Other asset items 11 11 13 14 6 3 3 9 20 86
Total Assets 143 130 136 147 164 164 195 217 278 317

Cash Flow (consolidated, figures in Rs Cr.)

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
+ Cash from Operating Activity -3 -2 31 11 28 7 47 35 55 47
Profit Before Tax & Extraordinary Items 14 -12 9 9 22 27 35 30 70 58
Depreciation 2 1 1 1 1 2 1 2 8 9
Interest (Net) 3 1 1 1 -2 -1 -3 -8 -7 -11
Profit / Loss on Sale of Assets 0 0 0 0 0 0 0 0 0 0
Profit / Loss on Sale of Investments 0 0 0 0 0 -1 -1 0 0 0
Provisions & Write-offs (Net) -13 0 0 0 0 0 0 1 -1 0
Receivables 2 14 4 -1 9 -3 -6 9 -2 -4
Inventories -8 -4 19 3 0 0 9 5 0 1
Trade Payables -1 0 3 0 6 -1 -2 -9 2 2
Direct Taxes Paid -3 0 2 -2 -3 -7 -7 -9 -8 -12
+ Cash from Investing Activity 41 -3 -1 -11 -2 -26 -58 -25 -45 -36
Purchase of Fixed Assets 0 -4 -2 -2 0 -1 0 0 0 0
Sale of Fixed Assets 43 0 1 3 0 1 1 0 36 0
Purchase of Investments 0 0 0 -11 -4 -25 0 0 0 0
Sale of Investments 0 0 0 0 0 0 41 1 0 0
Interest Received 0 0 0 0 2 2 3 7 8 10
Others -2 0 0 0 0 -1 -103 -33 -88 -46
+ Cash from Financing Activity -34 -1 -6 -1 -7 -18 0 -9 -12 -12
Proceeds from Issue of Shares 0 0 0 0 0 0 0 6 3 7
Proceeds from Other Long-Term Borrowings 0 0 0 1 0 0 0 0 0 0
Proceeds from Short-Term Borrowings 0 0 0 0 0 0 0 0 0 0
Repayment of Long-Term Borrowings 0 0 -2 0 0 -7 0 0 0 0
Repayment of Short-Term Borrowings 0 0 -2 0 0 0 0 0 0 0
Repayment of Financial Liabilities 0 0 0 0 0 0 0 -1 -1 -1
Dividend Paid 0 0 -1 -1 -3 -10 0 -13 -13 -17
Others -30 0 0 0 -4 0 0 0 0 0
Net Cash Flow 5 -6 24 0 19 -36 -11 2 -2 -1